ナノロボティクス市場規模、シェア、動向、2032年までの世界予測

世界のナノロボティクス市場は、2025年の22億7,000万米ドルから2032年には45億2,000万米ドルに拡大し、2026年から2032年にかけて年平均成長率（CAGR）10.6%で成長すると予測されています。ナノロボティクス市場の成長は、ナノテクノロジー研究開発への政府および民間投資の増加、そして研究機関と産業界との連携拡大によって牽引され、技術開発が加速すると予想されます。さらに、材料科学、半導体研究、ナノスケール製造におけるナノロボティクスの利用拡大も市場拡大を支えています。

調査範囲：

本調査レポートは、ナノロボティクス市場を、タイプ（ナノマニピュレーターおよびナノロボティクスシステム）、展開（in vivo、in vitro/ex vivo、その他）、技術（磁気駆動、バイオハイブリッド/生物学的推進、音響/超音波推進、その他）、用途（薬物送達、診断、ナノ手術および組織修復、その他）、エンドユーザー（病院および臨床センター、製薬およびバイオテクノロジー企業、研究機関および大学、医療機器OEM、その他）、および地域（北米、欧州、アジア太平洋、その他の地域）に分類しています。本レポートでは、ナノロボティクス市場における主要な推進要因、制約要因、課題、機会を解説し、2032年までの市場予測を示しています。また、ナノロボティクス市場エコシステムに含まれるすべての企業のリーダーシップマッピングと分析も含まれています。

レポート購入の主なメリット

本レポートは、ナノロボティクス市場全体および各サブセグメントの収益数値の近似値に関する情報を提供することで、市場リーダー企業および新規参入企業を支援します。本レポートは、関係者が競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。また、市場動向を把握し、主要な市場牽引要因、制約要因、課題、機会に関する情報を提供するのにも役立ちます。

本レポートでは、以下の点について洞察を提供しています。

ナノロボティクス市場の成長に影響を与える主要な推進要因（ナノテクノロジーと再生医療への注目度の高まり、ナノロボティクスに対する政府の支援と投資の増加）、制約要因（明確な規制枠組みの欠如と開発・製造コストの高騰）、機会（腫瘍学および精密治療の需要増加、ナノロボティクスのナビゲーションとモニタリングを強化するAI誘導画像システムの利用増加）、そして課題（ナノロボティクスシステムの商業化）の分析

• 製品開発／イノベーション：ナノロボティクス市場における今後の技術、研究開発活動、最新の製品・サービス投入に関する詳細な洞察
• 市場開発：有望な市場に関する包括的な情報 ― 本レポートでは、様々な地域におけるナノロボティクス市場を分析しています
• 市場多様化：ナノロボティクス市場における新製品・サービス、未開拓地域、最近の動向、投資に関する包括的な情報
• 競合評価：ナノロボティクス市場における主要企業（日本電子株式会社（日本）、サーモフィッシャーサイエンティフィック株式会社（米国）、ブルカー（ドイツ）、日立ハイテク株式会社（日本）、ツァイスグループ（ドイツ）、オックスフォード・インストゥルメンツ（英国）、EVグループ（オーストリア）、パークシステムズ（韓国）など）の市場シェア、成長戦略、サービス提供に関する詳細な評価

Report Description

The global nanorobotics market is projected to grow from USD 2.27 billion in 2025 to USD 4.52 billion by 2032, at a CAGR of 10.6% from 2026 to 2032. The growth of the nanorobotics market is expected to be driven by rising government and private investments in nanotechnology R&D, along with expanding collaboration between research institutes and industry players, which are accelerating technology development. In addition, increasing use of nanorobotics in materials science, semiconductor research, and nanoscale manufacturing is supporting market expansion.

“By type, the nano-manipulator segment holds the largest share during the forecast period.”

The nano-manipulators segment of the nanorobotics market is expected to hold the largest market share during the forecast period. Nano-manipulators are well-established tools for precise positioning, probing, and manipulation at the nanoscale, making them essential for materials science, semiconductor research, and life-science studies. Their strong market presence is supported by proven performance, relatively higher technology maturity, and seamless integration into existing research workflows. In addition, continuous demand for high-precision nanoscale analysis and experimentation across academic and industrial settings continues to drive large-scale adoption, reinforcing nano-manipulators’ dominant share in the global nanorobotics market.

“Pharma & biotech companies segment expected to register the highest CAGR during the forecast period.”

The pharma & biotech companies segment is expected to grow at the highest CAGR during the forecast period, driven by growing demand for advanced drug development and precision treatment technologies. Pharma and biotech companies are increasingly adopting nanorobotics systems for targeted drug delivery, nanosurgery, tissue repair, and in vivo research to improve therapeutic efficacy and reduce side effects. Rising investments in biologics, regenerative medicine, and personalized therapies are accelerating the need for exact and controllable nanoscale solutions.

“China to be the largest market for nanorobotics in the Asia Pacific.”

China is expected to continue dominating the nanorobotics market in the Asia Pacific region during the forecast period. The country has established a robust ecosystem of universities, national laboratories, and research institutes actively engaged in nanorobotics development, supporting both in vitro and in vivo applications. In addition, China’s growing pharmaceutical and biotechnology industries are accelerating the adoption of nanorobotics for drug delivery, diagnostics, and next-generation medical research. Strong policy support, increasing R&D investments, and close collaboration between academia and industry further strengthen China’s leadership position, making it the dominant contributor to nanorobotics market growth in the Asia Pacific region.

Extensive primary interviews were conducted with key industry experts in the nanorobotics market to determine and verify market sizes across segments and subsegments. The breakdown of primary participants for the report is shown below. The study includes insights from various industry experts, including component suppliers, Tier 1 Companies, and OEMs. The breakup of the primaries is as follows:

• By Company Type: Tier 1 – 20%, Tier 2 – 45%, and Tier 3 – 35%
• By Designation: C-level Executives – 35%, Directors – 340%, and Others – 20%
• By Region: North America – 25%, Europe – 20%, Asia Pacific – 45%, and RoW – 10%

Note: Three tiers of companies are defined based on their total revenue as of 2024: tier 1: revenue of USD 500 million or more; tier 2: revenue between USD 100 million and USD 500 million; and tier 3: revenue of USD 100 million or less. Other designations include sales and marketing executives, researchers, and members of various nanorobotics organizations.

JEOL LTD. (Japan), Thermo Fisher Scientific Inc. (US), Bruker (Germany), Hitachi High-Tech Corporation (Japan), ZEISS Group (Germany), Oxford Instruments (UK), EV Group (Austria), Park Systems (South Korea), among others, are the key players in the nanorobotics market. The study includes an in-depth competitive analysis of these key players in the nanorobotics market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

This research report categorizes the nanorobotics market by type (nano-manipulators and nanorobotics systems), deployment (in vivo, in vitro/ex vivo, and other), technology (magnetic actuation, biohybrid/biological propulsion, acoustic/ultrasound propulsion, and other), application (drug delivery, diagnostics, nano-surgery & tissue repair, and other), end user (hospitals & clinical centers, pharma & biotech companies, research institutes & universities, medical devices OEMs, and other), and region (North America, Europe, Asia-Pacific, and RoW). The report describes the major drivers, restraints, challenges, and opportunities in the nanorobotics market and forecasts the market through 2032. The report also includes leadership mapping and analysis of all the companies included in the nanorobotics market ecosystem.

Key Benefits of Buying the Report

The report will help the market leaders/new entrants in this market by providing information on the closest approximations of the revenue numbers for the overall nanorobotics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (rising focus on nanotechnology and regenerative medicine and increasing government support and level of investment in nanorobotics) restraints (Lack of clear regulatory frameworks and high development & manufacturing costs), opportunities (growing demand of oncology and precision therapeutics and increasing use of AI-guided imaging systems enhancing nanorobotics navigation and monitoring) and challenges (commercialization of nanorobotics systems) influencing the growth of the nanorobotics market
• Product Development/Innovation: Detailed insights into upcoming technologies, research and development activities, and the latest product and service launches in the nanorobotics market
• Market Development: Comprehensive information about lucrative markets – the report analyzes the nanorobotics market across varied regions
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the nanorobotics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as JEOL LTD. (Japan), Thermo Fisher Scientific Inc. (US), Bruker (Germany), Hitachi High-Tech Corporation (Japan), ZEISS Group (Germany), Oxford Instruments (UK), EV Group (Austria), Park Systems (South Korea), among others in the nanorobotics market

Table of Contents

1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 25
1.3.2 INCLUSIONS & EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 26
1.3.4 CURRENCY CONSIDERED 27
1.3.5 UNIT CONSIDERED 27
1.4 STAKEHOLDERS 27
2 EXECUTIVE SUMMARY 28
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 28
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 29
2.3 DISRUPTIVE TRENDS SHAPING NANOROBOTICS MARKET 30
2.4 HIGH-GROWTH SEGMENTS 30
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 31
3 PREMIUM INSIGHTS 32
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NANOROBOTICS MARKET 32
3.2 NANOROBOTICS MARKET, BY TYPE 32
3.3 NANOROBOTICS MARKET, BY APPLICATION 33
3.4 NANOROBOTICS MARKET, BY TECHNOLOGY 33
3.5 NANOROBOTICS MARKET, BY END USER 34
3.6 NANOROBOTICS MARKET, BY COUNTRY 34
4 MARKET OVERVIEW 35
4.1 INTRODUCTION 35
4.2 MARKET DYNAMICS 35
4.2.1 DRIVERS 36
4.2.1.1 Strong healthcare demand for better clinical translation and investment 36
4.2.1.2 Increasing government support and level of investment in nanorobotics 36
4.2.1.3 Rising focus on nanotechnology and regenerative medicine 37
4.2.2 RESTRAINTS 37
4.2.2.1 Lack of clear regulatory frameworks and high development & manufacturing costs 38
4.2.3 OPPORTUNITIES 38
4.2.3.1 Growing demand of oncology and precision therapeutics 38
4.2.3.2 Increasing use of AI-guided imaging systems, enhancing nanorobotics navigation and monitoring 39
4.2.4 CHALLENGES 39
4.2.4.1 Commercialization of nanorobotics systems 39
4.3 UNMET NEEDS & WHITE SPACES 40
4.3.1 UNMET NEEDS IN NANOROBOTICSS MARKET 40
4.3.2 WHITE SPACE OPPORTUNITIES 40
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 40
4.4.1 INTERCONNECTED MARKETS 40
4.4.2 CROSS-SECTOR OPPORTUNITIES 41
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 41
4.5.1 MARKET DYNAMICS FOR NANOROBOTICS MARKET 41
5 INDUSTRY TRENDS 42
5.1 INTRODUCTION 42
5.2 PORTER’S FIVE FORCES ANALYSIS 42
5.2.1 THREAT OF NEW ENTRANTS 43
5.2.2 THREAT OF SUBSTITUTES 43
5.2.3 BARGAINING POWER OF SUPPLIERS 43
5.2.4 BARGAINING POWER OF BUYERS 44
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 44
5.3 MACROECONOMIC OUTLOOK 44
5.3.1 INTRODUCTION 44
5.3.2 GDP TRENDS AND FORECAST 44
5.3.3 TRENDS IN GLOBAL MEDICAL OEMS 46
5.3.4 TRENDS IN GLOBAL HOSPITALS AND CLINICAL CENTERS 46
5.4 VALUE CHAIN ANALYSIS 46
5.5 ECOSYSTEM ANALYSIS 48
5.5.1 ROLE IN ECOSYSTEM 48
5.6 PRICING ANALYSIS 49
5.6.1 AVERAGE SELLING PRICE FOR ELECTRON MICROSCOPES, BY TYPE, 2025 49
5.6.2 AVERAGE SELLING PRICE TREND OF ELECTRON MICROSCOPES, BY TYPE, 2022–2025 50
5.6.3 AVERAGE SELLING PRICE TREND OF SEM ELECTRON MICROSCOPES,
BY REGION, 2022–2025 51
5.7 TRADE ANALYSIS 51
5.7.1 IMPORT DATA FOR HS CODE 901210 51
5.7.2 EXPORT DATA FOR HS CODE 901210 52
5.8 KEY CONFERENCES & EVENTS, 2026–2027 53
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 55
5.10 INVESTMENT & FUNDING SCENARIO, 2023–2025 56
5.11 CASE STUDY ANALYSIS 56
5.11.1 KLEINDIEK NANOTECHNIK ENABLING IN-SITU NANO-MANIPULATION INSIDE SEM AND TEM 56
5.12 IMPACT OF 2025 US TARIFF ON NANOROBOTICS MARKET 57
5.12.1 KEY TARIFF RATES 57
5.12.2 PRICE IMPACT ANALYSIS 59
5.12.3 IMPACT ON VARIOUS COUNTRIES/REGIONS 59
5.12.3.1 US 59
5.12.3.2 Europe 59
5.12.3.3 Asia Pacific 60
5.12.4 IMPACT ON END USERS 60
6 TECHNOLOGICAL ADVANCEMENT, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 61
6.1 KEY TECHNOLOGIES 61
6.1.1 NANOMEDICINE AND PRECISION DRUG DELIVERY SYSTEMS 61
6.1.2 BIO-HYBRID AND CELL-DRIVEN NANOROBOTS 61
6.2 COMPLEMENTARY TECHNOLOGIES 61
6.2.1 ADVANCED MEDICAL IMAGING AND NAVIGATION SYSTEMS 61
6.2.2 ARTIFICIAL INTELLIGENCE & MACHINE LEARNING 61
6.3 ADJACENT TECHNOLOGIES 62
6.3.1 LAB-ON-A-CHIP DEVICES 62
6.4 TECHNOLOGY/PRODUCT ROADMAP 62
6.5 PATENT ANALYSIS 64
6.5.1 LIST OF APPLIED/GRANTED PATENTS 64
6.6 IMPACT OF AI/GEN AI ON NANOROBOTICS MARKET 66
6.6.1 TOP USE CASES AND MARKET POTENTIAL 66
6.6.2 BEST PRACTICES IN NANOROBOTICS MARKET 67
6.6.3 CASE STUDIES OF AI IMPLEMENTATION 67
6.6.4 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS 67
6.6.5 CLIENTS’ READINESS TO ADOPT AI 68
7 REGULATORY LANDSCAPE 69
7.1 INTRODUCTION 69
7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
7.3 STANDARDS AND REGULATIONS RELATED TO NANOROBOTICS 71
7.3.1 STANDARDS 71
7.3.1.1 ISO 71
7.3.1.2 REACH 71
7.3.1.3 NIOSH 71

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 72
8.1 DECISION-MAKING PROCESS 72
8.2 KEY STAKEHOLDERS & BUYING CRITERIA 73
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 73
8.2.2 BUYING CRITERIA 74
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 75
8.4 UNMET NEEDS FROM VARIOUS END USERS 75
9 NANOROBOTICS MARKET, BY TYPE 77
9.1 INTRODUCTION 78
9.2 NANO-MANIPULATORS 79
9.2.1 ADVANCEMENTS IN NANO-MANIPULATION TECHNOLOGIES TO ACCELERATE RESEARCH AND INDUSTRIAL ADOPTION 79
9.3 NANOROBOTIC SYSTEMS 82
9.3.1 RISING FOCUS ON AUTONOMOUS NANOROBOTICS SYSTEMS TO AID MARKET EXPANSION 82
10 NANOROBOTICS MARKET, BY TECHNOLOGY 85
10.1 INTRODUCTION 86
10.2 MAGNETIC ACTUATION 87
10.2.1 GROWTH OF HEALTHCARE SECTOR TO DRIVE DEMAND FOR MAGNETICALLY ACTUATED NANOROBOTICS 87
10.3 BIOHYBRID/BIOLOGICAL PROPULSION 87
10.3.1 INCREASING FOCUS ON BIOCOMPATIBLE AND AUTONOMOUS NANOROBOTIC SYSTEMS TO PROPEL MARKET GROWTH 87
10.4 ACOUSTIC/ULTRASOUND PROPULSION 87
10.4.1 ADVANCEMENTS IN NON-CONTACT TECHNOLOGIES TO SUPPORT ADOPTION OF ACOUSTIC/ULTRASOUND PROPULSION 87
10.5 OTHER TECHNOLOGIES 88
11 NANOROBOTICS MARKET, BY DEPLOYMENT 89
11.1 INTRODUCTION 90
11.2 IN-VIVO DEPLOYMENT 91
11.2.1 RISING INVESTMENT IN NANOMEDICINE AND TRANSLATIONAL RESEARCH TO AID MARKET GROWTH 91
11.3 IN-VITRO/EX-VIVO DEPLOYMENT 91
11.3.1 CONTINUOUS INVESTMENTS IN LIFE-SCIENCE RESEARCH AND MATERIALS INNOVATION TO AUGMENT MARKET GROWTH 91
11.4 OTHER DEPLOYMENTS 92

12 NANOROBOTICS MARKET, BY APPLICATION 93
12.1 INTRODUCTION 94
12.2 DIAGNOSTICS 95
12.2.1 GROWING ADOPTION OF IN-VITRO DIAGNOSTICS, LAB-ON-CHIP, AND POINT-OF-CARE TESTING TO BOOST MARKET GROWTH 95
12.3 DRUG DELIVERY 96
12.3.1 INCREASING PREVALENCE OF CHRONIC AND COMPLEX DISEASES TO FUEL MARKET GROWTH 96
12.4 NANO SURGERY & TISSUE REPAIR 96
12.4.1 RISING DEMAND FOR MINIMALLY INVASIVE AND HIGH-PRECISION SURGICAL INTERVENTIONS TO PROPEL MARKET GROWTH 96
12.5 OTHER APPLICATIONS 97
13 NANOROBOTICS MARKET, BY END USER 98
13.1 INTRODUCTION 99
13.2 RESEARCH INSTITUTES & UNIVERSITIES 100
13.2.1 DEMAND FOR NANO-MANIPULATORS, NANOPROBING SYSTEMS, AND EXPERIMENTAL NANOROBOTIC PLATFORMS TO DRIVE MARKET 100
13.3 HOSPITALS & CLINICAL CENTERS 104
13.3.1 RISING DEMAND FOR MINIMALLY INVASIVE AND PRECISION-GUIDED MEDICAL PROCEDURES TO AID MARKET GROWTH 104
13.4 PHARMA & BIOTECH COMPANIES 108
13.4.1 RISING R&D SPENDING TO IMPROVE DRUG DISCOVERY EFFICIENCY AND SUCCESS RATES 108
13.5 MEDICAL OEMS 112
13.5.1 DEMAND FOR MINIATURIZED AND HIGH-PRECISION MEDICAL DEVICES AND COMPONENTS TO AUGMENT MARKET GROWTH 112
13.6 OTHER END USERS 116
14 NANOROBOTICS MARKET, BY REGION 120
14.1 INTRODUCTION 121
14.2 NORTH AMERICA 122
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 122
14.2.2 US 124
14.2.2.1 Early adoption of advanced medical technologies to support market growth 124
14.2.3 CANADA 125
14.2.3.1 Government funding and healthcare innovation to drive Canadian nanorobotics market 125
14.2.4 MEXICO 126
14.2.4.1 Strategic partnerships and nanotechnology platforms to fuel market growth 126

14.3 EUROPE 127
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 127
14.3.2 UK 129
14.3.2.1 Growing nanotechnology development programs to boost market demand 129
14.3.3 GERMANY 130
14.3.3.1 Growing nanotechnology research to improve market growth 130
14.3.4 FRANCE 131
14.3.4.1 Investments in research & development to fuel market growth 131
14.3.5 ITALY 132
14.3.5.1 Rising focus on precision healthcare and research infrastructure to support market growth 132
14.3.6 REST OF EUROPE 133
14.4 ASIA PACIFIC 134
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 134
14.4.2 CHINA 136
14.4.2.1 Growing number of collaborations for R&D in nanotechnology and life sciences to drive market 136
14.4.3 JAPAN 137
14.4.3.1 Rising R&D funding for biotechnology and nanotechnology to support market growth 137
14.4.4 INDIA 138
14.4.4.1 Increasing demand for advanced medical treatments to drive market 138
14.4.5 SOUTH KOREA 139
14.4.5.1 Increasing use in medical research and healthcare applications to fuel market demand 139
14.4.6 REST OF ASIA PACIFIC 140
14.5 REST OF THE WORLD 141
14.5.1 MACROECONOMIC OUTLOOK FOR REST OF THE WORLD 141
14.5.2 MIDDLE EAST & AFRICA 142
14.5.2.1 Rising oil & gas exploration activities to accelerate market growth 142
14.5.2.2 GCC countries 144
14.5.2.3 Rest of Middle East & Africa 144
14.5.3 SOUTH AMERICA 144
14.5.3.1 Growth in automotive, oil & gas, chemicals, and mining industries to augment market demand 144
15 COMPETITIVE LANDSCAPE 146
15.1 INTRODUCTION 146
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025 146
15.3 MARKET SHARE ANALYSIS, 2024 147
15.4 REVENUE ANALYSIS, 2022–2024 149
15.5 COMPANY VALUATION & FINANCIAL METRICS 150
15.5.1 COMPANY VALUATION 150
15.5.2 FINANCIAL METRICS 150
15.6 BRAND/PRODUCT COMPARISON 151
15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 151
15.7.1 STARS 151
15.7.2 EMERGING LEADERS 151
15.7.3 PERVASIVE PLAYERS 152
15.7.4 PARTICIPANTS 152
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 153
15.7.5.1 Company footprint 153
15.7.5.2 Region footprint 153
15.7.5.3 Type footprint 154
15.7.5.4 Deployment footprint 155
15.7.5.5 End-user footprint 155
15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 156
15.8.1 PROGRESSIVE COMPANIES 156
15.8.2 RESPONSIVE COMPANIES 156
15.8.3 DYNAMIC COMPANIES 156
15.8.4 STARTING BLOCKS 156
15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 157
15.8.5.1 Detailed list of key startups/SMEs 157
15.8.5.2 Competitive benchmarking of key startups/SMEs 158
15.9 COMPETITIVE SCENARIO 159
15.9.1 PRODUCT LAUNCHES 159
15.9.2 DEALS 160
15.9.3 OTHER DEVELOPMENTS 161
16 COMPANY PROFILES 162
16.1 KEY PLAYERS 162
16.1.1 BRUKER 162
16.1.1.1 Business overview 162
16.1.1.2 Products/Solutions/Services offered 163
16.1.1.3 Recent developments 164
16.1.1.3.1 Product launches 164
16.1.1.3.2 Deals 164
16.1.1.4 MnM view 165
16.1.1.4.1 Key strengths 165
16.1.1.4.2 Strategic choices 165
16.1.1.4.3 Weaknesses & competitive threats 165
16.1.2 JEOL LTD. 166
16.1.2.1 Business overview 166
16.1.2.2 Products/Solutions/Services offered 167
16.1.2.3 Recent developments 167
16.1.2.3.1 Product launches 167
16.1.2.4 MnM view 168
16.1.2.4.1 Key strengths 168
16.1.2.4.2 Strategic choices 168
16.1.2.4.3 Weaknesses & competitive threats 168
16.1.3 THERMO FISHER SCIENTIFIC INC. 169
16.1.3.1 Business overview 169
16.1.3.2 Products/Solutions/Services offered 170
16.1.3.3 Recent developments 171
16.1.3.3.1 Product launches 171
16.1.3.4 MnM view 171
16.1.3.4.1 Key strengths 171
16.1.3.4.2 Strategic choices 171
16.1.3.4.3 Weaknesses & competitive threats 171
16.1.4 HITACHI HIGH-TECH CORPORATION 172
16.1.4.1 Business overview 172
16.1.4.2 Products/Solutions/Services offered 173
16.1.4.3 Recent developments 174
16.1.4.3.1 Product launches 174
16.1.4.3.2 Deals 175
16.1.4.4 MnM view 175
16.1.4.4.1 Key strengths 175
16.1.4.4.2 Strategic choices 175
16.1.4.4.3 Weaknesses & competitive threats 175
16.1.5 ZEISS GROUP 176
16.1.5.1 Business overview 176
16.1.5.2 Products/Solutions/Services offered 177
16.1.5.3 Recent developments 178
16.1.5.3.1 Product launches 178
16.1.5.3.2 Deals 178
16.1.5.3.3 Expansions 179
16.1.5.4 MnM view 179
16.1.5.4.1 Key strengths 179
16.1.5.4.2 Strategic choices 179
16.1.5.4.3 Weaknesses & competitive threats 179
16.1.6 PARK SYSTEMS 180
16.1.6.1 Business overview 180
16.1.6.2 Products/Solutions/Services offered 181
16.1.6.3 Recent developments 181
16.1.6.3.1 Product launches 181
16.1.6.3.2 Deals 181
16.1.6.3.3 Expansions 182
16.1.7 OXFORD INSTRUMENTS 183
16.1.7.1 Business overview 183
16.1.7.2 Products/Solutions/Services offered 184
16.1.8 EV GROUP (EVG) 185
16.1.8.1 Business overview 185
16.1.8.2 Products/Solutions/Services offered 185
16.1.9 THERANAUTILUS 186
16.1.9.1 Business overview 186
16.1.9.2 Products/Solutions/Services offered 186
16.1.10 CIQTEK CO., LTD. 187
16.1.10.1 Business overview 187
16.1.10.2 Products/Solutions/Services offered 187
16.1.10.3 Recent developments 188
16.1.10.3.1 Product launches 188
16.1.10.3.2 Deals 188
16.2 OTHER PLAYERS 189
16.2.1 IMINA TECHNOLOGIES SA 189
16.2.2 NANOBIOTIX 189
16.2.3 NANOLIVE 190
16.2.4 TORONTO NANO INSTRUMENTATION INC. 190
16.2.5 KLOCKE NANOTECHNIK GMBH 191
16.2.6 KLEINDIEK NANOTECHNIK GMBH 192
16.2.7 SMARACT GMBH 192
16.2.8 NANOSURF 193
16.2.9 GINKGO BIOWORKS 193
16.2.10 STEREOTAXIS, INC. 194
16.2.11 BIONAUT LABS, INC. 195
16.2.12 NOVASCAN TECHNOLOGIES, INC. 195
16.2.13 DNA NANOBOTS, INC. 196
16.2.14 ANGSTROM ADVANCED INC. 196
16.2.15 NENOVISION S.R.O. 197
17 RESEARCH METHODOLOGY 198
17.1 RESEARCH DATA 198
17.1.1 SECONDARY DATA 199
17.1.1.1 List of key secondary sources 199
17.1.1.2 Key data from secondary sources 199
17.1.2 PRIMARY DATA 200
17.1.2.1 List of primary interview participants 200
17.1.2.2 Breakdown of primaries 200
17.1.2.3 Key industry insights 201

17.1.3 SECONDARY AND PRIMARY RESEARCH 201
17.2 MARKET SIZE ESTIMATION 202
17.2.1 BOTTOM-UP APPROACH 202
17.2.1.1 Approach to arrive at market size using bottom-up analysis (demand side) 202
17.2.2 TOP-DOWN APPROACH 204
17.2.2.1 Approach to arrive at market size using top-down analysis (supply side) 204
17.3 DATA TRIANGULATION 205
17.4 STUDY ASSUMPTIONS 206
17.5 RISK ANALYSIS 207
17.6 RESEARCH LIMITATIONS 207
18 APPENDIX 208
18.1 DISCUSSION GUIDE 208
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 211
18.3 CUSTOMIZATION OPTIONS 213
18.4 RELATED REPORTS 213
18.5 AUTHOR DETAILS 214

LIST OF TABLES

TABLE 1 NANOROBOTICS MARKET: INCLUSIONS & EXCLUSIONS 26
TABLE 2 NANOROBOTICS MARKET: IMPACT OF PORTER’S FIVE FORCES 42
TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 44
TABLE 4 COMPANIES AND THEIR ROLE IN NANOROBOTICS ECOSYSTEM 48
TABLE 5 AVERAGE SELLING PRICE OF ELECTRON MICROSCOPES OFFERED BY KEY PLAYERS, BY TYPE, 2025 50
TABLE 6 IMPORT DATA FOR HS CODE 901210, BY COUNTRY, 2020–2024 (USD MILLION) 52
TABLE 7 EXPORT DATA FOR HS CODE 901210, BY COUNTRY, 2020–2024 (USD MILLION) 53
TABLE 8 KEY CONFERENCES & EVENTS IN NANOROBOTICS MARKET,
JANUARY 2026–DECEMBER 2027 53
TABLE 9 KLEINDIEK NANOTECHNIK ENABLING IN-SITU NANO-MANIPULATION INSIDE SEM AND TEM 56
TABLE 10 US-ADJUSTED RECIPROCAL TARIFF RATES 57
TABLE 11 EVOLUTION OF NANOROBOTICS TECHNOLOGIES 62
TABLE 12 LIST OF APPLIED/GRANTED PATENTS IN NANOROBOTICS MARKET, 2021–2025 64
TABLE 13 TOP USE CASES AND NANOROBOTICS MARKET POTENTIAL 66
TABLE 14 BEST PRACTICES FOR COMPANIES IMPLEMENTING USE CASES 67
TABLE 15 CASE STUDIES RELATED TO AI IMPLEMENTATION IN NANOROBOTICS MARKET 67
TABLE 16 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS 67
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP
THREE END USERS (%) 73
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS 74
TABLE 23 UNMET NEEDS IN NANOROBOTICS MARKE, BY END USER 76
TABLE 24 NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 78
TABLE 25 NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 78
TABLE 26 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 79
TABLE 27 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY TYPE,
2026–2032 (USD MILLION) 79
TABLE 28 NANO-MANIPULATORS: NANOROBOTICS MARKET FOR ELECTRON MICROSCOPY, BY TYPE, 2022–2025 (MILLION UNITS) 79
TABLE 29 NANO-MANIPULATORS: NANOROBOTICS MARKET FOR ELECTRON MICROSCOPY, BY TYPE, 2026–2032 (MILLION UNITS) 80
TABLE 30 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 80
TABLE 31 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY APPLICATION,
2026–2032 (USD MILLION) 80
TABLE 32 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY END USER,
2022–2025 (USD MILLION) 81
TABLE 33 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY END USER,
2026–2032 (USD MILLION) 81
TABLE 34 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY DEPLOYMENT,
2022–2025 (USD MILLION) 81
TABLE 35 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY DEPLOYMENT,
2026–2032 (USD MILLION) 82
TABLE 36 NANOROBOTIC SYSTEMS: NANOROBOTICS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 82
TABLE 37 NANOROBOTIC SYSTEMS: NANOROBOTICS MARKET, BY APPLICATION,
2026–2032 (USD MILLION) 83
TABLE 38 NANOROBOTIC SYSTEMS: NANOROBOTICS MARKET, BY END USER,
2022–2025 (USD MILLION) 83
TABLE 39 NANOROBOTIC SYSTEMS: NANOROBOTICS MARKET, BY END USER,
2026–2032 (USD MILLION) 83
TABLE 40 NANOROBOTIC SYSTEMS: NANOROBOTICS MARKET, BY DEPLOYMENT,
2022–2025 (USD MILLION) 84
TABLE 41 NANOROBOTICS SYSTEMS: NANOROBOTICS MARKET, BY DEPLOYMENT,
2026–2032 (USD MILLION) 84
TABLE 42 NANOROBOTICS MARKET, BY TECHNOLOGY, 2022–2025 (USD MILLION) 86
TABLE 43 NANOROBOTICS MARKET, BY TECHNOLOGY, 2026–2032 (USD MILLION) 87
TABLE 44 NANOROBOTICS MARKET, BY DEPLOYMENT, 2022–2025 (USD MILLION) 90
TABLE 45 NANOROBOTICS MARKET, BY DEPLOYMENT, 2026–2032 (USD MILLION) 90
TABLE 46 IN-VIVO DEPLOYMENT: NANOROBOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 91
TABLE 47 IN-VIVO DEPLOYMENT: NANOROBOTICS MARKET, BY TYPE,
2026–2032 (USD MILLION) 91
TABLE 48 IN-VITRO/EX-VIVO DEPLOYMENT: NANOROBOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 92
TABLE 49 IN-VITRO/EX-VIVO DEPLOYMENT: NANOROBOTICS MARKET, BY TYPE,
2026–2032 (USD MILLION) 92
TABLE 50 OTHER DEPLOYMENTS: NANOROBOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 92
TABLE 51 OTHER DEPLOYMENTS: NANOROBOTICS MARKET, BY TYPE,
2026–2032 (USD MILLION) 92
TABLE 52 NANOROBOTICS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 94
TABLE 53 NANOROBOTICS MARKET, BY APPLICATION, 2026–2032 (USD MILLION) 95
TABLE 54 DIAGNOSTICS: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 95
TABLE 55 DIAGNOSTICS: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 95
TABLE 56 DRUG DELIVERY: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 96
TABLE 57 DRUG DELIVERY: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 96
TABLE 58 NANO SURGERY & TISSUE REPAIR: NANOROBOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 97
TABLE 59 NANO SURGERY & TISSUE REPAIR: NANOROBOTICS MARKET, BY TYPE,
2026–2032 (USD MILLION) 97
TABLE 60 OTHER APPLICATIONS: NANOROBOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 97
TABLE 61 OTHER APPLICATIONS: NANOROBOTICS MARKET, BY TYPE,
2026–2032 (USD MILLION) 97
TABLE 62 NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 99
TABLE 63 NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 100
TABLE 64 RESEARCH INSTITUTES & UNIVERSITIES: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 100
TABLE 65 RESEARCH INSTITUTES & UNIVERSITIES: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 101
TABLE 66 RESEARCH INSTITUTES & UNIVERSITIES: NANOROBOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 101
TABLE 67 RESEARCH INSTITUTES & UNIVERSITIES: NANOROBOTICS MARKET, BY REGION, 2026–2032 (USD MILLION) 101
TABLE 68 RESEARCH INSTITUTES & UNIVERSITIES: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 102
TABLE 69 RESEARCH INSTITUTES & UNIVERSITIES: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 102
TABLE 70 RESEARCH INSTITUTES & UNIVERSITIES: EUROPE NANOROBOTICS MARKET,
BY COUNTRY, 2022–2025 (USD MILLION) 102
TABLE 71 RESEARCH INSTITUTES & UNIVERSITIES: EUROPE NANOROBOTICS MARKET,
BY COUNTRY, 2026–2032 (USD MILLION) 103
TABLE 72 RESEARCH INSTITUTES & UNIVERSITIES: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 103
TABLE 73 RESEARCH INSTITUTES & UNIVERSITIES: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 103
TABLE 74 RESEARCH INSTITUTES & UNIVERSITIES: ROW NANOROBOTICS MARKET,
BY COUNTRY, 2022–2025 (USD MILLION) 104
TABLE 75 RESEARCH INSTITUTES & UNIVERSITIES: ROW NANOROBOTICS MARKET,
BY COUNTRY, 2026–2032 (USD MILLION) 104
TABLE 76 HOSPITALS & CLINICAL CENTERS: NANOROBOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 104
TABLE 77 HOSPITALS & CLINICAL CENTERS: NANOROBOTICS MARKET, BY TYPE,
2026–2032 (USD MILLION) 105
TABLE 78 HOSPITALS & CLINICAL CENTERS: NANOROBOTICS MARKET, BY REGION,
2022–2025 (USD MILLION) 105
TABLE 79 HOSPITALS & CLINICAL CENTERS: NANOROBOTICS MARKET, BY REGION,
2026–2032 (USD MILLION) 105
TABLE 80 HOSPITALS & CLINICAL CENTERS: NORTH AMERICA NANOROBOTICS MARKET,
BY COUNTRY, 2022–2025 (USD MILLION) 106
TABLE 81 HOSPITALS & CLINICAL CENTERS: NORTH AMERICA NANOROBOTICS MARKET,
BY COUNTRY, 2026–2032 (USD MILLION) 106
TABLE 82 HOSPITALS & CLINICAL CENTERS: EUROPE NANOROBOTICS MARKET,
BY COUNTRY, 2022–2025 (USD MILLION) 106
TABLE 83 HOSPITALS & CLINICAL CENTERS: EUROPE NANOROBOTICS MARKET,
BY COUNTRY, 2026–2032 (USD MILLION) 107
TABLE 84 HOSPITALS & CLINICAL CENTERS: ASIA PACIFIC NANOROBOTICS MARKET,
BY COUNTRY, 2022–2025 (USD MILLION) 107
TABLE 85 HOSPITALS & CLINICAL CENTERS: ASIA PACIFIC NANOROBOTICS MARKET,
BY COUNTRY, 2026–2032 (USD MILLION) 107
TABLE 86 HOSPITALS & CLINICAL CENTERS: ROW NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 108
TABLE 87 HOSPITALS & CLINICAL CENTERS: ROW NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 108
TABLE 88 PHARMA & BIOTECH COMPANIES: NANOROBOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 108
TABLE 89 PHARMA & BIOTECH COMPANIES: NANOROBOTICS MARKET, BY TYPE,
2026–2032 (USD MILLION) 109
TABLE 90 PHARMA & BIOTECH COMPANIES: NANOROBOTICS MARKET, BY REGION,
2022–2025 (USD MILLION) 109
TABLE 91 PHARMA & BIOTECH COMPANIES: NANOROBOTICS MARKET, BY REGION,
2026–2032 (USD MILLION) 109
TABLE 92 PHARMA & BIOTECH COMPANIES: NORTH AMERICA NANOROBOTICS MARKET,
BY COUNTRY, 2022–2025 (USD MILLION) 110
TABLE 93 PHARMA & BIOTECH COMPANIES: NORTH AMERICA NANOROBOTICS MARKET,
BY COUNTRY, 2026–2032 (USD MILLION) 110
TABLE 94 PHARMA & BIOTECH COMPANIES: EUROPE NANOROBOTICS MARKET,
BY COUNTRY, 2022–2025 (USD MILLION) 110
TABLE 95 PHARMA & BIOTECH COMPANIES: EUROPE NANOROBOTICS MARKET,
BY COUNTRY, 2026–2032 (USD MILLION) 111
TABLE 96 PHARMA & BIOTECH COMPANIES: ASIA PACIFIC NANOROBOTICS MARKET,
BY COUNTRY, 2022–2025 (USD MILLION) 111
TABLE 97 PHARMA & BIOTECH COMPANIES: ASIA PACIFIC NANOROBOTICS MARKET,
BY COUNTRY, 2026–2032 (USD MILLION) 111
TABLE 98 PHARMA & BIOTECH COMPANIES: ROW NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 112
TABLE 99 PHARMA & BIOTECH COMPANIES: ROW NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 112
TABLE 100 MEDICAL OEMS: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 112
TABLE 101 MEDICAL OEMS: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 112
TABLE 102 MEDICAL OEMS: NANOROBOTICS MARKET, BY REGION,
2022–2025 (USD MILLION) 113
TABLE 103 MEDICAL OEMS: NANOROBOTICS MARKET, BY REGION,
2026–2032 (USD MILLION) 113
TABLE 104 MEDICAL OEMS: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 113
TABLE 105 MEDICAL OEMS: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY,
2026–2032 (USD MILLION) 114
TABLE 106 MEDICAL OEMS: EUROPE NANOROBOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 114
TABLE 107 MEDICAL OEMS: EUROPE NANOROBOTICS MARKET, BY COUNTRY,
2026–2032 (USD MILLION) 114
TABLE 108 MEDICAL OEMS: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 115
TABLE 109 MEDICAL OEMS: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY,
2026–2032 (USD MILLION) 115
TABLE 110 MEDICAL OEMS: ROW NANOROBOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 115
TABLE 111 MEDICAL OEMS: ROW NANOROBOTICS MARKET, BY COUNTRY,
2026–2032 (USD MILLION) 115
TABLE 112 OTHER END USERS: NANOROBOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 116
TABLE 113 OTHER END USERS: NANOROBOTICS MARKET, BY TYPE,
2026–2032 (USD MILLION) 116
TABLE 114 OTHER END USERS: NANOROBOTICS MARKET, BY REGION,
2022–2025 (USD MILLION) 116
TABLE 115 OTHER END USERS: NANOROBOTICS MARKET, BY REGION,
2026–2032 (USD MILLION) 117
TABLE 116 OTHER END USERS: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 117
TABLE 117 OTHER END USERS: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 117
TABLE 118 OTHER END USERS: EUROPE NANOROBOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 118
TABLE 119 OTHER END USERS: EUROPE NANOROBOTICS MARKET, BY COUNTRY,
2026–2032 (USD MILLION) 118
TABLE 120 OTHER END USERS: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 118
TABLE 121 OTHER END USERS: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY,
2026–2032 (USD MILLION) 119
TABLE 122 OTHER END USERS: ROW NANOROBOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 119
TABLE 123 OTHER END USERS: ROW NANOROBOTICS MARKET, BY COUNTRY,
2026–2032 (USD MILLION) 119
TABLE 124 NANOROBOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 121
TABLE 125 NANOROBOTICS MARKET, BY REGION, 2026–2032 (USD MILLION) 122
TABLE 126 NORTH AMERICA: NANOROBOTICS MARKET, BY END USER,
2022–2025 (USD MILLION) 123
TABLE 127 NORTH AMERICA: NANOROBOTICS MARKET, BY END USER,
2026–2032 (USD MILLION) 124
TABLE 128 NORTH AMERICA: NANOROBOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 124
TABLE 129 NORTH AMERICA: NANOROBOTICS MARKET, BY COUNTRY,
2026–2032 (USD MILLION) 124
TABLE 130 US: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 125
TABLE 131 US: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 125
TABLE 132 CANADA: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 126
TABLE 133 CANADA: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 126
TABLE 134 MEXICO: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 127
TABLE 135 MEXICO: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 127
TABLE 136 EUROPE: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 128
TABLE 137 EUROPE: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 129
TABLE 138 EUROPE: NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 129
TABLE 139 EUROPE: NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 129
TABLE 140 UK: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 130
TABLE 141 UK: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 130
TABLE 142 GERMANY: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 131
TABLE 143 GERMANY: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 131
TABLE 144 FRANCE: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 132
TABLE 145 FRANCE: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 132
TABLE 146 ITALY: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 132
TABLE 147 ITALY: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 133
TABLE 148 REST OF EUROPE: NANOROBOTICS MARKET, BY END USER,
2022–2025 (USD MILLION) 133
TABLE 149 REST OF EUROPE: NANOROBOTICS MARKET, BY END USER,
2026–2032 (USD MILLION) 133
TABLE 150 ASIA PACIFIC: NANOROBOTICS MARKET, BY END USER,
2022–2025 (USD MILLION) 135
TABLE 151 ASIA PACIFIC: NANOROBOTICS MARKET, BY END USER,
2026–2032 (USD MILLION) 136
TABLE 152 ASIA PACIFIC: NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 136
TABLE 153 ASIA PACIFIC: NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 136
TABLE 154 CHINA: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 137
TABLE 155 CHINA: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 137
TABLE 156 JAPAN: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 138
TABLE 157 JAPAN: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 138
TABLE 158 INDIA: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 139
TABLE 159 INDIA: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 139
TABLE 160 SOUTH KOREA: NANOROBOTICS MARKET, BY END USER,
2022–2025 (USD MILLION) 140
TABLE 161 SOUTH KOREA: NANOROBOTICS MARKET, BY END USER,
2026–2032 (USD MILLION) 140
TABLE 162 REST OF ASIA PACIFIC: NANOROBOTICS MARKET, BY END USER,
2022–2025 (USD MILLION) 140
TABLE 163 REST OF ASIA PACIFIC: NANOROBOTICS MARKET, BY END USER,
2026–2032 (USD MILLION) 141
TABLE 164 REST OF THE WORLD: NANOROBOTICS MARKET, BY END USER,
2022–2025 (USD MILLION) 141
TABLE 165 REST OF THE WORLD: NANOROBOTICS MARKET, BY END USER,
2026–2032 (USD MILLION) 142
TABLE 166 REST OF THE WORLD: NANOROBOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 142
TABLE 167 REST OF THE WORLD: NANOROBOTICS MARKET, BY COUNTRY,
2026–2032 (USD MILLION) 142
TABLE 168 MIDDLE EAST & AFRICA: NANOROBOTICS MARKET, BY END USER,
2022–2025 (USD MILLION) 143
TABLE 169 MIDDLE EAST & AFRICA: NANOROBOTICS MARKET, BY END USER,
2026–2032 (USD MILLION) 143
TABLE 170 MIDDLE EAST & AFRICA: NANOROBOTICS MARKET, BY REGION,
2022–2025 (USD MILLION) 143
TABLE 171 MIDDLE EAST & AFRICA: NANOROBOTICS MARKET, BY REGION,
2026–2032 (USD MILLION) 144
TABLE 172 SOUTH AMERICA: NANOROBOTICS MARKET, BY END USER,
2022–2025 (USD MILLION) 144
TABLE 173 SOUTH AMERICA: NANOROBOTICS MARKET, BY END USER,
2026–2032 (USD MILLION) 145
TABLE 174 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
NANOROBOTICS MARKET, JANUARY 2021–DECEMBER 2025 146
TABLE 175 MARKET SHARE ANALYSIS OF TOP FIVE PLAYERS IN
NANOROBOTICS MARKET, 2024 147
TABLE 176 NANOROBOTICS MARKET: REGION FOOTPRINT 153
TABLE 177 NANOROBOTICS MARKET: TYPE FOOTPRINT 154
TABLE 178 NANOROBOTICS MARKET: DEPLOYMENT FOOTPRINT 155
TABLE 179 NANOROBOTICS MARKET: END-USER FOOTPRINT 155
TABLE 180 NANOROBOTICS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 157
TABLE 181 NANOROBOTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE, END USER, AND REGION 158
TABLE 182 NANOROBOTICS MARKET: PRODUCT LAUNCHES,
JANUARY 2021–DECEMBER 2025 159
TABLE 183 NANOROBOTICS MARKET: DEALS, JANUARY 2021–DECEMBER 2025 160
TABLE 184 NANOROBOTICS MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–DECEMBER 2025 161
TABLE 185 BRUKER: COMPANY OVERVIEW 162
TABLE 186 BRUKER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 163
TABLE 187 BRUKER: PRODUCT LAUNCHES 164
TABLE 188 BRUKER: DEALS 164
TABLE 189 JEOL LTD.: COMPANY OVERVIEW 166
TABLE 190 JEOL LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 167
TABLE 191 JEOL LTD.: PRODUCT LAUNCHES 167
TABLE 192 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 169
TABLE 193 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 170
TABLE 194 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES 171
TABLE 195 HITACHI HIGH-TECH CORPORATION: COMPANY OVERVIEW 172
TABLE 196 HITACHI HIGH-TECH CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 173
TABLE 197 HITACHI HIGH-TECH CORPORATION: PRODUCT LAUNCHES 174
TABLE 198 HITACHI HIGH-TECH CORPORATION: DEALS 175
TABLE 199 ZEISS GROUP: COMPANY OVERVIEW 176
TABLE 200 ZEISS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 177
TABLE 201 ZEISS GROUP: PRODUCT LAUNCHES 178
TABLE 202 ZEISS GROUP: DEALS 178
TABLE 203 ZEISS GROUP: EXPANSIONS 179
TABLE 204 PARK SYSTEMS: COMPANY OVERVIEW 180
TABLE 205 PARK SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 181
TABLE 206 PARK SYSTEMS: PRODUCT LAUNCHES 181
TABLE 207 PARK SYSTEMS: DEALS 181
TABLE 208 PARK SYSTEMS: EXPANSIONS 182
TABLE 209 OXFORD INSTRUMENTS: COMPANY OVERVIEW 183
TABLE 210 OXFORD INSTRUMENTS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 184
TABLE 211 EV GROUP (EVG): COMPANY OVERVIEW 185
TABLE 212 EV GROUP (EVG): PRODUCTS/SOLUTIONS/SERVICES OFFERED 185
TABLE 213 THERANAUTILUS: COMPANY OVERVIEW 186
TABLE 214 THERANAUTILUS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 186
TABLE 215 CIQTEK CO., LTD.: COMPANY OVERVIEW 187
TABLE 216 CIQTEK CO.,LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 187
TABLE 217 CIQTEK CO.,LTD.: PRODUCT LAUNCHES 188
TABLE 218 CIQTEK CO.,LTD.: DEALS 188
TABLE 219 IMINA TECHNOLOGIES SA: COMPANY OVERVIEW 189
TABLE 220 NANOBIOTIX: COMPANY OVERVIEW 189
TABLE 221 NANOLIVE: COMPANY OVERVIEW 190
TABLE 222 TORONTO NANO INSTRUMENTATION INC.: COMPANY OVERVIEW 190
TABLE 223 KLOCKE NANOTECHNIK GMBH: COMPANY OVERVIEW 191
TABLE 224 KLEINDIEK NANOTECHNIK GMBH: COMPANY OVERVIEW 192
TABLE 225 SMARACT GMBH: COMPANY OVERVIEW 192
TABLE 226 NANOSURF: COMPANY OVERVIEW 193
TABLE 227 GINKGO BIOWORKS: COMPANY OVERVIEW 193
TABLE 228 STEREOTAXIS, INC.: COMPANY OVERVIEW 194
TABLE 229 BIONAUT LABS, INC.:COMPANY OVERVIEW 195
TABLE 230 NOVASCAN TECHNOLOGIES, INC.: COMPANY OVERVIEW 195
TABLE 231 DNA NANOBOTS, INC.: COMPANY OVERVIEW 196
TABLE 232 ANGSTROM ADVANCED INC.: COMPANY OVERVIEW 196
TABLE 233 NENOVISION S.R.O.: COMPANY OVERVIEW 197
TABLE 234 LIST OF KEY SECONDARY SOURCES IN NANOROBOTICS MARKET 199
TABLE 235 LIST OF PRIMARY INTERVIEW PARTICIPANTS IN NANOROBOTICS MARKET 200
TABLE 236 NANOROBOTICS MARKET: STUDY ASSUMPTIONS 206
TABLE 237 NANOROBOTICS MARKET: RISK ANALYSIS 207

LIST OF FIGURES

FIGURE 1 NANOROBOTICS MARKET SEGMENTATION & REGIONAL SCOPE 25
FIGURE 2 NANOROBOTICS MARKET: YEARS CONSIDERED 26
FIGURE 3 KEY INSIGHTS & MARKET SCENARIO 28
FIGURE 4 GLOBAL NANOROBOTICS MARKET, IN TERMS OF VALUE,
2026–2032 (USD MILLION) 28
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NANOROBOTICS MARKET, JANUARY 2022–DECEMBER 2025 29
FIGURE 6 DISRUPTIVE TRENDS INFLUENCING COMMON-MODE CHOKE DEMAND 30
FIGURE 7 HIGH-GROWTH SEGMENTS IN NANOROBOTICS MARKET, BY TYPE, DEPLOYMENT, END USER, AND REGION 30
FIGURE 8 ASIA PACIFIC TO BE LEADING MARKET DURING FORECAST PERIOD 31
FIGURE 9 RISING FOCUS ON NANOTECHNOLOGY AND REGENERATIVE MEDICINES
TO FUEL MARKET GROWTH 32
FIGURE 10 NANO-MANIPULATORS TO CAPTURE LARGEST MARKET SHARE BY 2032 32
FIGURE 11 DIAGNOSTICS TO ACCOUNT FOR LARGEST MARKET SHARE BY 2032 33
FIGURE 12 MAGNETIC ACTUATION TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 33
FIGURE 13 RESEARCH INSTITUTES & UNIVERSITIES TO BE LARGEST END USERS OF NANOROBOTICS FROM 2026 TO 2032 34
FIGURE 14 INDIA TO REGISTER HIGHEST CAGR IN NANOROBOTICS MARKET BETWEEN
2026 AND 2032 34
FIGURE 15 NANOROBOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 35
FIGURE 16 NANOROBOTICS MARKET: DRIVERS AND THEIR IMPACT 36
FIGURE 17 NANOROBOTICS MARKET: RESTRAINTS AND THEIR IMPACT 37
FIGURE 18 NANOROBOTICS MARKET: OPPORTUNITIES AND THEIR IMPACT 38
FIGURE 19 NANOROBOTICS MARKET: CHALLENGES AND THEIR IMPACT 39
FIGURE 20 NANOROBOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 43
FIGURE 21 NANOROBOTICS MARKET: VALUE CHAIN ANALYSIS 46
FIGURE 22 NANOROBOTICS MARKET: ECOSYSTEM ANALYSIS 48
FIGURE 23 AVERAGE SELLING PRICE OF ELECTRON MICROSCOPES, BY TYPE,
2025 (USD THOUSAND) 49
FIGURE 24 AVERAGE SELLING PRICE OF ELECTRON MICROSCOPES, BY TYPE,
2022–2025 (USD THOUSAND) 50
FIGURE 25 AVERAGE SELLING PRICE OF SEM ELECTRON MICROSCOPES, BY REGION,
2022–2025 (USD) 51
FIGURE 26 IMPORT DATA FOR HS CODE 901210, BY COUNTRY, 2020−2024 (USD MILLION) 51
FIGURE 27 EXPORT DATA FOR HS CODE 901210, BY COUNTRY, 2020−2024 (USD MILLION) 52
FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN
NANOROBOTICS MARKET 55
FIGURE 29 FUNDING SCENARIO IN NANOROBOTICS MARKET, 2023–2025 (USD MILLION) 56
FIGURE 30 NANOROBOTICS MARKET: PATENT ANALYSIS, 2015–2024 64
FIGURE 31 DECISION-MAKING FACTORS IN NANOROBOTICS MARKET 72
FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 73
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS 74
FIGURE 34 ADOPTION BARRIERS & INTERNAL CHALLENGES 75
FIGURE 35 NANOROBOTIC SYSTEMS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 78
FIGURE 36 MAGNETIC ACTUATION TO ACCOUNT FOR LARGEST MARKET SHARE BY 2032 86
FIGURE 37 IN-VIVO DEPLOYMENT TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 90
FIGURE 38 DIAGNOSTICS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 94
FIGURE 39 RESEARCH INSTITUTES & UNIVERSITIES TO COMMAND LARGEST MARKET SHARE 99
FIGURE 40 NANOROBOTICS MARKET, BY REGION, 2026 VS. 2032 (USD MILLION) 121
FIGURE 41 NORTH AMERICA: NANOROBOTICS MARKET SNAPSHOT 123
FIGURE 42 EUROPE: NANOROBOTICS MARKET SNAPSHOT 128
FIGURE 43 ASIA PACIFIC: NANOROBOTICS MARKET SNAPSHOT 135
FIGURE 44 NANOROBOTICS MARKET SHARE ANALYSIS (2024) 148
FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN NANOROBOTICS MARKET, 2022–2024 149
FIGURE 46 NANOROBOTICS MARKET: COMPANY VALUATION 150
FIGURE 47 NANOROBOTICS MARKET: FINANCIAL METRICS 150
FIGURE 48 NANOROBOTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 151
FIGURE 49 NANOROBOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 152
FIGURE 50 NANOROBOTICS MARKET: COMPANY FOOTPRINT 153
FIGURE 51 NANOROBOTICS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 157
FIGURE 52 BRUKER: COMPANY SNAPSHOT 163
FIGURE 53 JEOL LTD.: COMPANY SNAPSHOT 166
FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 170
FIGURE 55 HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT 173
FIGURE 56 ZEISS GROUP: COMPANY SNAPSHOT 177
FIGURE 57 PARK SYSTEMS: COMPANY SNAPSHOT 180
FIGURE 58 OXFORD INSTRUMENTS: COMPANY SNAPSHOT 184
FIGURE 59 NANOROBOTICS MARKET: RESEARCH DESIGN 198
FIGURE 60 KEY DATA FROM SECONDARY SOURCES IN NANOROBOTICS MARKET 199
FIGURE 61 NANOROBOTICS MARKET: BREAKDOWN OF PRIMARIES 200
FIGURE 62 KEY INSIGHTS FROM INDUSTRY EXPERTS IN NANOROBOTICS MARKET 201
FIGURE 63 SECONDARY AND PRIMARY RESEARCH IN NANOROBOTICS MARKET 201
FIGURE 64 RESEARCH FLOW IN NANOROBOTICS MARKET 202
FIGURE 65 NANOROBOTICS MARKET: BOTTOM-UP APPROACH 203
FIGURE 66 NANOROBOTICS MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE) 203
FIGURE 67 NANOROBOTICS MARKET: TOP-DOWN APPROACH 204
FIGURE 68 NANOROBOTICS MARKET: DATA TRIANGULATION 205

---

---